Mark C. Griffiths Named Carbogen Amcis CEO

New Carbogen Amcis CEO Mark Griffiths
New Carbogen Amcis CEO Mark Griffiths

Switzerland-based Carbogen Amcis, a pharmaceutical process development and API manufacturing company, announced that Mark C. Griffiths has been named chief executive officer, effective immediately. In his new role, Griffiths will have responsibility for the company's Swiss business and will report to Jay Vyas, managing director of Dishman Pharmaceuticals and Chemicals, Carbogen Amcis' parent company.

Griffiths has been associated with Carbogen Amcis as director of operations and chief executive officer for almost 10 years. Most recently, he has been working for the Dishman Group as operations advisor overseeing the design and construction of the group's large-scale manufacturing facilities for commercial supply of highly potent APIs (HPAPIs) in Shanghai, China, and Ahmedabad, India.

 

Company

Dishman Europe Ltd.

120 New Cavendish St.
W1W 6XX London

Company contact







Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.